The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation
2005 ◽
Vol 21
(9)
◽
pp. 1163-1171
◽
2019 ◽
Vol 15
(6)
◽
pp. 595-600
◽
2006 ◽
Vol 23
(8)
◽
pp. 1171-1178
◽